References
- Otto HH, Schirmeister T. Cysteine proteases and their inhibitors. Chem Rev 1997;97:133–71.
- Harmsen MM, Cornelissen JBWJ, Buijs HECM, Boersma WJA, Jeurissen SHM, van Milligen FJ. Identification of a novel Fasciola hepatica cathepsin L protease containing protective epitopes within the propeptide. Int J Parasitol 2004;34:675–82.
- Dalton JP, O’Neill S, Stack C, Collins P, Walshe A, Sekiya M, et al. Fasciola hepatica cathepsin L-like proteases: biology, function, and potential in the development of first generation liver fluke vaccines. Int J Parasitol 2003;33:1173–81.
- Howell RM. Collagenase activity of immature Fasciola hepatica. Nature 1966;209:713–14.
- Dalton JP, Heffernan M. Thiol proteases released in vitro by Fasciola hepatica. Mol Biochem Parasitol 1989;35:161–6.
- Leung D, Abbenante G, Fairlie DP. Protease inhibitors: current status and future prospects. J Med Chem 2000;43:305–41.
- Löser R, Schilling K, Dimmig E, Gütschow M. Interaction of papain-like cysteine proteases with dipeptide-derived nitriles. J Med Chem 2005;48:7688–707.
- Yadav MR, Shinde AK, Chouhan BS, Giridhar R, Menard R. Peptidomimetic 2-cyanopyrrolidines as potent selective cathepsin L inhibitors. J Enzyme Inhib Med Chem 2008;23:190–7.
- Gour-Salin BJ, Lachance P, Bonneau PR, Storer AC, Kirschke H, Broemme PR. E-64 analogs as inhibitors of cathepsin L and cathepsin S: importance of the S2–P2 interactions for potency and selectivity. Bioorg Chem 1994;22:227–41.
- Sheehy MJ. The design and synthesis of novel peptide derivatives as malarial protease inhibitors and electrochemical anion sensing receptors. PhD Thesis, Dublin City University, Ireland, 1999.
- Lim IT, Meroueh SO, Lee M, Heeg MJ, Mobashery S. Strategy in inhibition of cathepsin B, a target in tumor invasion and metastasis. J Am Chem Soc 2004;126:10271–7.
- Collins PR, Stack CM, O’Neill SM, Doyle S, Ryan T, Brennan GP, et al. Cathepsin L1, the major protease involved in liver fluke (Fasciola hepatica) virulence: propeptide cleavage sites and autoactivation of the zymogen secreted from gastrodermal cells. J Biol Chem 2004;279:17038–46.
- Goel A, Kenny PTM. Formation of b1-1 and the corresponding a1-1 product ions in the mass spectra of N-{para-(ferrocenyl)-benzoyl} dipeptide esters. Rapid Commun Mass Spectrom 2008;22:2398–401.
- Corry AJ, Goel A, Alley SR, Kelly PN, O’Sullivan D, Savage D, et al. N- ortho-Ferrocenyl benzoyl dipeptide esters: synthesis, structural characterization and in vitro anti-cancer activity of N-{ortho-(ferrocenyl)-benzoyl}-glycine-L-alanine ethyl ester and N-{ortho-(ferrocenyl)benzoyl}- L-alanine-glycine ethyl ester. J Organomet Chem 2007;692:1405–10.
- Kelly PN, Pretre A, Devoy S, O’Rielly I, Devery R, Goel A, et al. Synthesis, structural characterization and biological activity of novel N-(ferrocenylmethyl)benzene-carboxamide derivatives. J Organomet Chem 2007;692:1327–31.
- Smith AM, Dowd AJ, McGonigle S, Keegan PS, Brennan G, Trudgett A, et al. Purification of a cathepsin L-like proteinase secreted by adult Fasciola hepatica. Mol Biochem Parasitol 1993;62:1–8.
- Dowd AJ, Smith AM, McGonigle S, Dalton JP. Purification and characterisation of a second cathepsin L proteinase secreted by the parasitic trematode Fasciola hepatica. Eur J Biochem 1994;223:91–8.
- Robichaud J, Oballa R, Prasit P, Falgueyret JP, Percival MD, Wesolowski G, et al. A novel class of nonpeptidic biaryl inhibitors of human cathepsin K. J Med Chem 2003;46:3709-727.
- Greenspan PD, Clark KL, Cowen SD, McQuire LW, Tomassi RA, Farley DL, et al. N–arylaminonitriles as bioavailable peptidomimetic inhibitors of cathepsin B. Bioorg Med Chem Lett 2003;13:4121–4.
- Smart BE. Fluorine substituent effects (on bioactivity). J Fluorine Chem 2001;109:3–11.